Note: Ingredients listed on restricted chemical lists
EC/CAS
557-04-0
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
1
General Information
Revision date
2021-09-15
Product name
FLUTICASONE FUROATE/ VILANTEROL DRY POWDER INHALER
Product Synonyms
RELVAR ELLIPTA * BREO ELLIPTA * REVINTY ELLIPTA * REVINTY ELLIPTA 184/22 MCG
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Reproductive toxicity Category 1B Specific target organ toxicity, repeated Category 2 (Adrenal, bone, eye, immune exposure system)
Environmental hazards
Hazardous to the aquatic environment, Category 2
Long term hazards
OSHA defined hazards Not classified.
Signal word
Danger
Hazard statements
May damage fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure. Toxic to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapors/spray. Avoid release to the environment. Wear protective gloves/protective clothing/eye protection/face protection.
Response
If exposed or concerned: Get medical advice/attention. Collect spillage.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health
Classified (HNOC)
hazards.
Additional information
100% of the mixture consists of component(s) of unknown acute dermal toxicity. 100% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment.